Anita Eileen Garloff, NP
Psychiatric/Mental Health · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 17
- 3 carriers
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Anita Eileen Garloff’s office at (855) 501-1004 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G21386 · Cancelled
Licence status: Cancelled · since 1971 · Loma Linda University School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$21,432 in 2024
Medicaid paid $21,432 for 88 billed services this clinician did in 2024, up to 19 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 88 | $21,432 |
| 2024 | 88 | 1 | 19 | $21,432 |
| 2023 | 201 | 1 | 23 | $47,316 |
| 2022 | 249 | 1 | 24 | $63,212 |
| 2021 | 260 | 1 | 22 | $63,305 |
| 2020 | 86 | 1 | 16 | $19,284 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 201 | $47,316 |
2022
| Return visit (30+ min) | 249 | $63,212 |
2021
| Return visit (30+ min) | 260 | $63,305 |
2020
| Return visit (30+ min) | 86 | $19,284 |
Drugs they prescribed that Part D paid
$1,273
Pharmacies billed $1,273 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 44) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
44 generic and 0 brand-name prescriptions · $1,273 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 44 | 13 | 0% (0) | 0% | $1,273 |
| 2023 | 27 | None | 0% (0) | 0% | $926 |
| 2022 | 15 | None | 0% (0) | 0% | $221 |
| 2021 | 23 | None | 0% (0) | None | $6,266 |
| 2020 | 33 | None | 0% (0) | None | $6,656 |
| 2016 | 369 | 40 | 0% (0) | 8% | $28,962 |
| 2015 | 254 | 29 | 0% (0) | 10% | $25,560 |
| 2014 | 47 | None | 0% (0) | 38% | $13,882 |
| 2013 | 453 | 38 | 0% (0) | 25% | $86,929 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Zolpidem | 12 | $6 | $0 |
2016: 15 drugs
| Dextroamphetamine-Amphetamine | 24 | $2,322 | $97 |
| Dextroamphetamine Sulfate | 11 | $2,296 | $209 |
| Venlafaxine | 14 | $977 | $70 |
| Venlafaxine Hcl Er | 30 | $570 | $19 |
| Quetiapine | 16 | $435 | $27 |
| Lamotrigine | 17 | $230 | $14 |
| Trazodone | 26 | $216 | $8 |
| Lorazepam | 25 | $201 | $8 |
| Sertraline | 14 | $177 | $13 |
| Alprazolam | 20 | $173 | $9 |
| Buspirone | 11 | $142 | $13 |
| Topiramate | 19 | $121 | $6 |
| Zolpidem | 11 | $82 | $7 |
| Clonazepam | 16 | $80 | $5 |
| Thiothixene | 11 | $48 | $4 |
2015: 8 drugs
| Methylphenidate Er | 11 | $4,078 | $371 |
| Dextroamphetamine Sulfate | 20 | $3,890 | $194 |
| Viibryd | 13 | $2,582 | $199 |
| Dextroamphetamine-Amphetamine | 21 | $2,457 | $117 |
| Bupropion Xl | 20 | $660 | $33 |
| Lorazepam | 17 | $182 | $11 |
| Alprazolam | 14 | $101 | $7 |
| Trazodone | 15 | $84 | $6 |
2013: 14 drugs
| Latuda | 24 | $20,800 | $867 |
| Risperdal Consta | 16 | $17,511 | $1,094 |
| Seroquel Xr | 11 | $6,736 | $612 |
| Quetiapine | 16 | $5,801 | $363 |
| Olanzapine | 14 | $4,848 | $346 |
| Bupropion Xl | 17 | $1,090 | $64 |
| Escitalopram | 12 | $608 | $51 |
| Haloperidol | 12 | $502 | $42 |
| Clonazepam | 36 | $393 | $11 |
| Trihexyphenidyl | 21 | $339 | $16 |
| Lorazepam | 29 | $339 | $12 |
| Zolpidem | 32 | $154 | $5 |
| Lamotrigine | 14 | $107 | $8 |
| Fluoxetine | 13 | $79 | $6 |
Money from drug and device companies
$87 in 2025
A payment is not proof that care is biased.
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $87 | 3 payments
|
See all 3 published payments
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-06 | Caplyta | $32 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-09 | Caplyta | $34 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-25 | Caplyta | $21 |
Professional record
- NPI
- 1306065990
- Licence
- CA 21386, CA RN558558California G21386: Cancelled
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X); Federal specialty code 163WP0808X (163WP0808X)
- Mailing address
- 3835 N Freeway Blvd Ste 100, Sacramento, CA, 95834
- NPI first listed
- 2007-04-24
- NPI last updated
- 2026-05-18
- NPI record certified
- 2026-05-18
This is when the NPI record was last certified, not a medical board exam.